How Much Melatonin Should You Take? 1 mg vs 3 mg vs 5 mg Explained

Melatonin dose questions sound simple: should you take 1 mg, 3 mg or 5 mg? The evidence does not support one universal “best” number. Dose interacts with timing, age, circadian phase, formulation and the reason you are using melatonin. That means a higher number on the label is not automatically stronger in the way consumers often assume—and a lower dose is not automatically the right choice for everyone.

Quick Answer
For adults, Health Canada’s current oral melatonin monograph allows 0.1–10 mg per day for most supported uses and 0.5–10 mg for jet lag. Those ranges are regulatory boundaries, not a recommendation to aim high. Biogénique Melatonin currently provides 5 mg per tablet and its marketed label directs adults to take one tablet once per day, at or before bedtime. If you are using this product, follow that label rather than splitting, doubling or re-dosing based on a research paper.

There Is No Universal “Best” Melatonin Dose

Melatonin is not a simple dose-response story where more reliably produces more sleep. Several controlled trials show useful effects at relatively low doses, while other studies show benefits at higher doses in specific circumstances. The populations, timing and outcomes differ, so the studies should not be stacked as if they were a head-to-head ranking of 1 mg, 3 mg and 5 mg for every person.

The practical question is therefore not “What is the strongest dose?” It is “What dose and timing fit the intended use, the product label and the person taking it?” If your main question is the mechanism rather than dose, see our guide to what melatonin does for sleep. [INTERNAL LINK: BLOG 01 WHEN LIVE]

What Health Canada’s Adult Dose Range Actually Means

Health Canada’s oral melatonin monograph, updated December 19, 2025, permits 0.1–10 mg per day for adult sleep-related uses other than jet lag, and 0.5–10 mg per day for jet lag. The monograph also supports melatonin only when needed for occasional sleeplessness and directs use 30–60 minutes before bedtime at the ingredient-monograph level.

The upper end of a permitted range is not a target. It means products can be licensed within that range when their specific formulation, indication and label meet Health Canada requirements. For an actual product, the product label controls how that product should be used.

What Does Research Say About Around 1 mg?

A small double-blind crossover study in 15 healthy middle-aged adults compared single evening doses of 0.3 mg and 1.0 mg with placebo. The 1 mg dose increased actual sleep time and sleep efficiency in that study. Another study in 12 healthy young adults found that 0.3 mg and 1.0 mg, given two to four hours before habitual bedtime, reduced sleep-onset latency.

Those results show that low doses can be biologically active. They do not prove that 1 mg is the optimal dose for insomnia, that everyone should start at 1 mg, or that a person using a labelled 5 mg product should alter the tablet to imitate the research protocol.

What Does Research Say About 3 mg?

In a 2001 double-blind placebo-controlled study of adults over 50, participants received 0.1 mg, 0.3 mg or 3 mg 30 minutes before bedtime for one week in randomized order. Among those with reduced sleep efficiency, all three doses improved sleep, while 0.3 mg restored sleep efficiency and nighttime melatonin levels. The 3 mg dose also caused melatonin levels to remain elevated into daylight hours and produced a measurable drop in body temperature.

That is a useful warning against the assumption that a larger dose is automatically “better.” It is also a small older study in a specific population, so it should not be converted into a personal dosing rule.

What Does Research Say About 5 mg?

Five milligrams is also a legitimate studied dose. In a 2006 randomized controlled study of 36 healthy adults aged 18–30 under a forced-desynchrony protocol, both 0.3 mg and 5 mg improved sleep efficiency similarly during circadian phases when the body’s own melatonin was absent. The effect depended on circadian phase, not simply on choosing the higher dose.

Jet-lag research tells a slightly different story. In a randomized trial after eastward travel across six to eight time zones, 0.5 mg fast-release and 5 mg fast-release melatonin were both effective overall; the 5 mg dose produced stronger sleep-promoting effects on sleep quality and latency. That is jet-lag evidence—not proof that 5 mg is always superior for ordinary bedtime use.

Research snapshot: dose is only one variable

Dose discussed

What selected studies show

What they do NOT prove

~1 mg

Low-dose trials in healthy adults found sleep effects at 1 mg.

That 1 mg is ideal for everyone or that a 5 mg tablet should be split.

3 mg

A small older-adult trial found sleep benefit, but daytime melatonin stayed elevated after 3 mg.

That 3 mg is universally better than lower doses.

5 mg

Studied in circadian and jet-lag settings; can have meaningful sleep-promoting effects.

That 5 mg works faster or better for every sleep problem.

Is 5 mg of Melatonin Too Much?

For an adult, 5 mg is within Health Canada’s current oral-monograph range and it matches the current Biogénique Melatonin label. So 5 mg is not automatically “too much.” But it is equally wrong to call 5 mg the universal ideal dose. Individual response varies, and research shows that lower doses can produce meaningful effects in some settings.

If a clinician recommends a different dose for your situation, that is a different decision from modifying a finished product yourself. With Biogénique Melatonin 5 mg, the label directs one whole tablet once daily. Do not double the dose, take extra tablets after waking in the night, or assume that more will solve persistent sleeplessness.

Biogénique Melatonin 5 mg: Follow the Current Marketed Label

The current marketed Biogénique Melatonin 5 mg product contains 5 mg of melatonin (N-acetyl-5-methoxytryptamine) per tablet, 30 tablets, NPN 80063547. The current label directs adults to take one tablet once per day, at or before bedtime. This product-specific direction is the one to follow for the product currently on shelf.

  • Do not drive or use machinery for 5 hours after taking melatonin.

  • For use beyond 4 weeks, consult a health care practitioner.

  • Do not use if pregnant or breastfeeding.

  • Avoid alcohol and other products that cause drowsiness, and follow the full medication/condition warnings on the label.

Dose and Timing Are Different Questions

A dose can be reasonable and still be taken at the wrong time for the intended effect. Melatonin acts both as a sleep-promoting signal and as a circadian timing signal, which is why research protocols vary so much in when the dose is given. If your question is when to take melatonin rather than how much, see our timing guide. [INTERNAL LINK: BLOG 02 WHEN LIVE]

For Biogénique’s current product, follow the product label. Do not use a timing schedule from a low-dose circadian study as permission to change the labelled dose or frequency.

What Lot PK240514 Quality Testing Can—and Cannot—Tell You

Biogénique’s current Quality Control / COA page lists Melatonin 5 mg, NPN 80063547, lot PK240514. The finished-tablet COA reports weight variation, friability, thickness, hardness, disintegration, microbial/pathogen testing and heavy-metal results. The tablet disintegrated in 2 minutes against a specification of not more than 30 minutes; the microbial and pathogen results met their listed limits; and the heavy-metal results were below the listed specifications. The tested lot met the listed specifications.

That COA answers finished-product quality questions; it does not provide a displayed active-ingredient assay result that should be used to prove the exact melatonin dose. Dose claims in this article therefore come from the current NPN/product label, not from inferring potency from the COA.

3X PUR™ interpretation
Pureté: microbial, pathogen and heavy-metal results.  Qualité: finished-tablet physical specifications.  Performance: the listed disintegration test can be discussed as a tablet-performance measure. 3X PUR™ is Biogénique’s framework for interpreting lot testing, not a certification issued by the laboratory.

A Practical Dose Decision Framework

Use this sequence instead of chasing the biggest milligram number:

  1. Define the problem. Occasional sleeplessness, jet lag and a shifted body clock are not the same use case.

  2. Read the exact product label. Ingredient-level monograph ranges do not replace product-specific directions.

  3. Keep dose and timing separate. A dose that appears in a study may have been given at a very different circadian time.

  4. Do not self-escalate. If the labelled dose seems ineffective, taking more is not automatically the next step.

  5. Escalate persistent sleep problems to a professional. Health Canada advises consultation if sleeplessness persists for more than 4 weeks.

Frequently Asked Questions

Is 1 mg of melatonin enough?

It can be biologically active, and small controlled studies have reported sleep effects around 1 mg. Whether it is appropriate for you depends on the product, indication, timing and individual factors. It does not mean you should split a 5 mg Biogénique tablet to create an unlabelled dose.

Is 3 mg better than 1 mg?

Not necessarily. A small older-adult trial found benefits at 0.1, 0.3 and 3 mg, but the 3 mg dose kept melatonin levels elevated into daylight hours. More exposure did not translate into a simple “better” conclusion.

Is 5 mg melatonin a high dose?

Five milligrams sits within Health Canada’s adult oral-monograph range and is the labelled strength of the current Biogénique product. It is a meaningful dose, but “high” is less useful than asking whether it matches the licensed product direction and your intended use.

Can I take two 5 mg tablets if one does not work?

Do not automatically double the dose. Biogénique’s current label directs one tablet once per day. If sleep problems persist or the product is not helping as expected, discuss the issue with a pharmacist or other health professional rather than self-escalating.

What about melatonin for children or teenagers in Canada?

As of June 2, 2026, melatonin sold for sleep-related use in people under 18 is prescription-only in Canada. Health Canada states that currently licensed non-prescription melatonin NHPs are indicated for adults only.

Bottom Line

There is no single melatonin dose that wins for everyone. Controlled research shows that low doses can work in some settings, 3 mg can produce prolonged exposure in some people, and 5 mg has evidence in circadian and jet-lag contexts. The correct takeaway is not “lower is always better” or “more is stronger.” It is to match the dose to the intended use and follow the actual product label.

For the current Biogénique Melatonin 5 mg product, that means adults take one tablet once per day, at or before bedtime. If sleeplessness lasts more than four weeks, or if you need a different dosing strategy, move the question to a health professional rather than increasing the dose yourself.

Related Biogénique Resources

Evidence & Compliance Note

This article keeps three evidence layers separate. (1) Biogénique product facts come from the current marketed label/NPN records: 5 mg per tablet, 30 tablets, NPN 80063547 and one tablet once per day at or before bedtime. (2) Health Canada ingredient-level information supplies the adult oral-monograph dose ranges, supported uses and safety framework. (3) External clinical studies describe specific research doses, populations, timing and outcomes; they are not presented as authorized Biogénique product claims or personal dosing instructions.

References

1. Health Canada. Melatonin - Oral Monograph. Natural and Non-prescription Health Products Directorate. Updated December 19, 2025.

2. Health Canada. Notice of amendment: pediatric sleep-related melatonin use became prescription-only under age 18 effective June 2, 2026.

3. Zhdanova IV, et al. Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab. 2001;86(10):4727-4730. PMID 11600532.

4. Attenburrow ME, Cowen PJ, Sharpley AL. Low dose melatonin improves sleep in healthy middle-aged subjects. Psychopharmacology. 1996;126(2):179-181. PMID 8856838.

5. Zhdanova IV, et al. Effects of low oral doses of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep. 1996;19(5):423-431. PMID 8843534.

6. Wyatt JK, et al. Sleep-facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep. 2006;29(5):609-618. PMID 16774150.

7. Suhner A, et al. Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiol Int. 1998;15(6):655-666. PMID 9844753.

8. Biogénique Melatonin 5 mg. Current product page. Product facts checked against Drive label/NPN records.

9. Biogénique Quality Control. Melatonin 5 mg, NPN 80063547, lot PK240514.

Disclaimer

This article is for general educational purposes and is not medical advice. Follow the product label and consult a qualified health professional if you have a medical condition, take medications, are pregnant or breastfeeding, have persistent sleep problems, or need individualized dosing guidance.